Pulmatrix PULM 深 沪
已收盘 10-02 16:00:00 美东时间
1.57
+0.030
+1.95%
华盛通- 最 高1.5987
- 今 开1.59
- 成交量 1.53万股
- 最 低 1.48
- 昨 收 1.54
- 总市值 573.41万
- 52周最高 5.235
- 市盈率 静 --
- 换手率 0.42%
- 52周最低 1.16
- 委 比 -89.58%
- 总股本 365.23万
- 历史最高 4235.00
- 量 比 1.01
- 振 幅 7.71%
- 历史最低 1.16
- 每 手 1
- 风险率 1.27%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Pulmatrix Q2 EPS $(0.29) Up From $(0.42) YoY
Pulmatrix (NASDAQ:PULM) reported quarterly losses of $(0.29) per share. This is a 30.95 percent increase over losses of $(0.42) per share from the same period last year.
08-13 20:52
Pulmatrix GAAP EPS of -$0.29
Pulmatrix press release (PULM): Q2 GAAP EPS of -$0.29. The Company's total cash and cash equivalents balance as of June 30, 2026, was $2.2 million, in addition to $0.7 million in restricted cash that ...
08-13 20:17
并购调查律所对PULM、SLP、OLN、HUN四起交易发起股东权益审查
并购集体诉讼律师事务所Monteverde & Associates PC宣布，正对四起上市公司并购交易发起股东权益调查，涉及Pulmatrix、...
07-11 03:53
Pulmatrix Q1 EPS $(0.32) Up From $(0.50) YoY
Pulmatrix (NASDAQ:PULM) reported quarterly losses of $(0.32) per share. This is a 36 percent increase over losses of $(0.50) per share from the same period last year.
05-15 20:23
Pulmatrix Signs Agreement To Acquire Eos SENOLYTIX; Financial Terms Undisclosed
Pulmatrix, Inc. (Nasdaq: PULM) ("Pulmatrix") and Eos SENOLYTIX, Inc. ("Eos"), a biotechnology company developing novel gerotherapeutic peptides targeting mitochondrial dysfunction in aging-related diseases, today jointly
03-26 20:03
Pulmatrix shares are trading lower after a planned acquisition was rejected.
Pulmatrix shares are trading lower after a planned acquisition was rejected.
03-03 03:48
Pulmatrix Q4 EPS $(0.25) Up From $(0.55) YoY
Pulmatrix (NASDAQ:PULM) reported quarterly losses of $(0.25) per share. This is a 54.55 percent increase over losses of $(0.55) per share from the same period last year.
02-26 21:19
